Why the study?
Cardiotoxicity from 5-FU is uncommon but potentially life-threatening, requiring better preparation among clinicians to recognize and manage chemotherapy-induced coronary artery vasospasm.
Continuous 5-fluorouracil infusion can cause life-threatening coronary artery vasospasm mimicking myocardial infarction, which may be effectively managed with intravenous calcium channel blockers.
Answers are grounded in this paper and cite their sources.
continuous infusion as a trigger for MI-mimicking vasospasm treatable.
5-fluorouracil (5-FU) is a fluorinated, pyrimidine analog, antineoplastic agent that is used in the treatment of several solid organ cancers. Cardiotoxicity is uncommon but life-threatening manifestations such as myocardial infarction may manifest owing to 5-FU-induced coronary artery spasm. Administering smaller doses of the drug, more frequently than not, decreases the risk of cardiotoxicity compared to large doses or with continuous infusions. We present a case of ST-segment elevation in a patient without known coronary artery disease who had presented following continuous 5-FU infusion. Coronary angiogram confirmed absence of coronary artery disease and intravenous calcium channel blockers administration was commensurate with the patient’s improvement in symptoms. We discuss the literature on 5-FU and its association with coronary artery spasm, and also briefly review chemotherapy-induced cardiotoxicities to help better prepare internists and other primary health care providers to face similar challenges, particularly of the uncommon but potentially life-threatening manifestations.
No takes yet. Share an insight, caveat, or question.
Ariyarajah et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: